Single-Cell Genome Sequencing Technology Market
Single-Cell Genome Sequencing Technology Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Single-Cell Genome Sequencing Technology Market Size and Growth
The Single-Cell Genome Sequencing Technology market is experiencing significant growth, driven by advancements in genomic research and personalized medicine. Valued at approximately $1.5 billion in 2023, the market is projected to expand at a CAGR of over 10% through 2030, reflecting increasing demand for innovative diagnostic tools and therapies.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Fludigim
◍ QIAGEN
◍ Illumina
◍ F Hoffmann-La Roche Ltd.
◍ Thermo Fisher Scientific, Inc.
◍ Bio-Rad
◍ 10X Genomics, Inc.
◍ Oxford Nanopore Technologies
◍ BGI
◍ Pacific Biosciences
◍ Tecan Group
◍ Novogene Co. Ltd.
◍ Takara Bio, Inc.
The Single-Cell Genome Sequencing Technology Market features key players like Illumina, Thermo Fisher Scientific, and 10X Genomics, driving innovation and providing advanced solutions. These companies enhance market growth through improved technologies and strategic collaborations, catering to academic and clinical research needs, thereby expanding their customer base and sales.
- Illumina: Approximately $4.1 billion
- Thermo Fisher: Approximately $39 billion
- 10X Genomics: Approximately $440 million
Request Sample Report
Market Segmentation
By Application
◍ Academic and research laboratories
◍ Biotechnology and biopharmaceutical companies
◍ Clinics
◍ Others
Request Sample Report
By Product
NGS
PCR
qPCR
Microarray
MDA
Market Growth
Request Sample Report
$ X Billion USD
